Art

J-GLOBAL ID：201902220582346541   Reference number：19S1466051

Serum hepatocyte growth factor and interleukin-6 are effective prognostic markers for non-small cell lung cancer

Author (10)： Ujiie, Hideki (Department of Thoracic Surgery, Saitama Cancer Center) ,  Ujiie, Hideki (Department of Medical Oncology, Graduate School of Medicine, Chiba University) ,  Ujiie, Hideki (Department of Clinical Molecular Biology, Graduate School of Medicine, Chiba University) ,  Akiyama, Hirohiko (Department of Thoracic Surgery, Saitama Cancer Center) ,  Nakajima, Yuki (Department of Thoracic Surgery, Saitama Cancer Center) ,  Okada, Daisuke (Department of Thoracic Surgery, Saitama Cancer Center) ,  Yoshino, Naoyuki (Department of Thoracic Surgery, Saitama Cancer Center) ,  Tomida, Mikio (Research Institute for Clinical Oncology, Saitama Cancer Center) ,  Takiguchi, Yuichi (Department of Medical Oncology, Graduate School of Medicine, Chiba University) ,  Tanzawa, Hideki (Department of Clinical Molecular Biology, Graduate School of Medicine, Chiba University)
Material： Anticancer Research
Volume： 32  Issue： 8  Page： 3251-3258  Publication year： 2012 
JST Material Number： SCOPUS  ISSN： 0250-7005  CODEN： ANTRD 
Country of issue： Greece (GRC)  Language： English (EN)

Terms in the title (2)： ARE ,  Cancer